Skip to main content
Virology Journal logoLink to Virology Journal
. 2010 Jul 13;7:154. doi: 10.1186/1743-422X-7-154

Concerns regarding hepatitis B vaccination and post-vaccination test among Brazilian dentists

Vera Lúcia S Resende 1,#, Mauro Henrique G Abreu 2,#, Saul M Paiva 3,✉,#, Rosângela Teixeira 4,#, Isabela A Pordeus 3,#
PMCID: PMC2909964  PMID: 20626908

Abstract

Background

Hepatitis B infection is the major cause of acute and chronic liver disease, cirrhosis and hepatocellular carcinoma worldwide and has long been recognized as an occupational hazard among dentists. The aim of the present study was to examine factors associated to the self-reporting of hepatitis B vaccination and immunization status among dentists working in the city of Belo Horizonte, Brazil.

Methods

A cross-sectional survey was carried out with 1302 dentists in Belo Horizonte, Brazil. After signing a term of informed consent, the participants answered a structured questionnaire on their knowledge regarding their vaccination and immunization status against hepatitis B. Data on demographic, behavioural and occupational exposure aspects were also collected through questionnaires.

Results

The results revealed that 73.8% of the dentists reported having received three doses of the vaccine. Multivariate analysis revealed that gender (p = 0.006), use of individual protective equipment (p = 0.021), history of blood transfusion (p = 0.024) and history of illicit drug use (p = 0.013) were independently associated with vaccination against hepatitis B. Only 14.8% had performed a post-vaccination test. The use of individual protective equipment (p = 0.038), dentists who asked patients about hepatitis during dental treatment (p < 0.001), a family history of hepatitis B (p = 0.003) and work experience (p < 0.05) were independently associated with the post-vaccination test.

Conclusions

Although there were a large number of vaccinated dentists in Belo Horizonte, the percentage was less than what was expected, as Brazil offers the National Program of Viral Hepatitis Vaccination, which provides free hepatitis B vaccinations to all healthcare workers. Despite being part of a high risk group for contamination, most of the dentists did not know their immunization status.

Background

Hepatitis B virus (HBV) is the major cause of acute and chronic liver disease, cirrhosis and hepatocellular carcinoma worldwide and has long been recognized as an occupational hazard among dentists [1-6]. A third of the world population (two billion people) has evidence of hepatitis exposure and an estimated 400 million are actively infected [3,7]. HBV is one of the major diseases of mankind and is a serious global public health problem [8,9]. HBV is transmitted primarily through parenteral and sexual exposure to HBsAg-positive blood or other body fluids from individuals who are chronic HBV carriers or have acute hepatitis B [2]. These chronically infected individuals are at high risk of death from cirrhosis of the liver and liver cancer, diseases that kill about one million people each year [10,11].

As the dental profession involves the use of small, sharp instruments contaminated with blood or other fluids, there is ample opportunity for inadvertent skin wounds to the operator and staff [1,2,12]. Such accidents include the possibility of transmission of hepatitis B, hepatitis C and human immunodeficiency virus (HIV) [13]. To decrease the risk of HBV infection, it is recommended that dental personnel receive immunization against HBV and use individual protective equipment, such as gloves, to prevent blood-borne infection during dental procedures [1,11].

The hepatitis B vaccine has been available since 1982 and, since 1990, has been recommended for healthcare workers whose activities frequently expose them to blood [7,10,11,14]. However, 5 to 10% of normal subjects do not produce the anti-hepatitis B surface antibody (anti-HBs) after receiving a standard course of HBV vaccine [7,15,16]. Thus, post-vaccination testing one to three months following the third dose of vaccine is recommended for healthcare workers who have contact with blood [7]. Previous studies carried out in other countries have revealed different proportions of self-reported vaccination, ranging from 40.3% to 97.0% [17-23]. The proportion of dentists who have had their antibody titer evaluated ranges from 36.5% to 47.9% [20,21]. In Brazil, one study found that only 73.1% of dentists had been submitted to the three doses of the vaccine [24].

There is little information on factors associated to adherence to the vaccination and the evaluation of immunization status regarding hepatitis B among dentists. The aim of the present study was to examine factors associated to the self-reporting of hepatitis B vaccination and immunization status among dentists working in the city of Belo Horizonte, Brazil.

Methods

This is a cross-sectional study nested in a larger study assessing factors associated to the seroprevalence of hepatitis C among dentists in the city of Belo Horizonte, Brazil. The dentists were first contacted, enrolled and invited to take part in the study in November 2004, when all dentists registered at the Minas Gerais Dental Council were required to elect the administrative board of the council. Belo Horizonte is the capital of the state of Minas Gerais and is an industrialized city with about 2.4 million inhabitants. The sample size was calculated to give a 95% confidence interval, 0.75% precision level [25] and using a 3% prevalence of hepatitis C [10]. The inclusion criteria were dentists living and working in the city of Belo Horizonte and registered at the Minas Gerais Dental Council. This group consists of a finite population of 2766 dentists. The minimal sample size to satisfy the requirements was estimated as 1156 dentists. Taking into account the possibility of losses, a correction factor of 1.2 was adopted, totalling an expected sample size of 1387 dentists. These dentists scheduled a visit at the clinical analysis laboratory of the Medical School of the Federal University of Minas Gerais. A total sample of 1302 dentists (response rate = 93.9%) answered the questionnaire between December 2004 and June 2006. The sampling strategy is detailed in a previous article [26]. All participants signed a term of informed consent and data were collected on demographic, behavioural and occupational exposure aspects.

Questionnaire

A self-administered questionnaire consisting of twenty open-ended and close-ended items was used for the data collection. The drafting of this questionnaire complied with all steps proposed by previous studies [27,28]. Once the purpose of the study and its conceptual basis were defined, the drafting of the items was carried out by means of a broad-based review of the literature [29-32]. Content validation was performed to determine the suitability of the theoretical content and functionality of the questionnaire. Item selection, adaptation and additional inclusions were then performed based on the opinion of an expert in research and marketing. An opinion was subsequently formed by a commission made up of professionals from different dental institutions and specialties. Unanimity in the approval of the questionnaire was required for validation. Suggestions for changes were heeded when brought up repeatedly by different commission members. Response options were organized vertically. All survey items were constructed in the same format in order to avoid placing emphasis on any specific item [26].

In the present study, the following variables were taken into account:

1- Personal and behavioural data

Gender; sexual behaviour (unprotected homo/hetero sex with a casual partner); blood transfusion; previous history of hepatitis in participant or family member; and use of illicit injection drugs. Since the latter variable is quite sensitive, this point was addressed in combination with exposure factors, such as the use of piercing and tattoos, history of any kind of transplant, dialysis, colonoscopy and chemotherapy.

2- Professional, behavioural and occupational exposure data

Work experience; workplace; field of work; use of individual protective equipment (IPE); vaccination for hepatitis B; immunization against hepatitis B; history and number of needle stick accidents with visible bleeding; dental assistance for patients with hepatitis; and whether the dentists' clinical dental chart contains a question on a history of hepatitis.

As individuals may go to school at any time in their lives and the number of years of professional activity may be more important than age in representing exposure to risk factors, the age of the participants was not inquired, but rather the duration of activity (work experience). To analyze the influence of work experience, the sample was categorized into four groups: less than 10 years; 10 to 20 years; 21 to 30 years; and 30 years or more. The workplace was considered public, private or both.

Data were analyzed using the Statistical Package for the Social Sciences (SPSS for Windows, version 17.0, SPSS Inc, Chicago, IL, USA). Bivariate analysis was the initial analytic strategy (Fisher's exact test and Pearson's chi-square test). Multivariate Poisson regression with robust variance was then performed. Vaccination for hepatitis B and immunization against hepatitis B were the dependent variables. The level of significance was set at α = 0.05.

Results

Among the total number of dentists surveyed, 87.1% (n = 1134) answered the question on hepatitis B vaccination and 74.8% (n = 974) answered the question on immunization for hepatitis B. Among the study sample (n = 1302), 73.9% reported having received the three doses of the vaccine. There was an association between vaccination against hepatitis B and gender (p = 0.003), use of IPE (p = 0.001), blood transfusion (p = 0.006) and combined factors (p = 0.026) in the univariate analysis (Table 1). The multivariate analysis revealed that women had a 1.06-fold (95%CI: 1.02-1.10) greater frequency of vaccination against hepatitis B than men. Dentists who reported the use of IPE had a 1.05-fold (95%CI: 1.01-1.09) greater prevalence of vaccination. Dentists who reported having received no blood transfusions had a 1.10-fold (95%CI: 1.01-1.21) greater prevalence of vaccination. Dentists reported having no combined risk factors had a 1.08-fold (95%CI: 1.02-1.15) greater prevalence of vaccination (Table 2).

Table 1.

Factors associated with self-reporting of hepatitis B vaccination among Brazilian dentists, Belo Horizonte, 2005

Hepatitis B vaccination p-value
Yes No Total
Gender
 Male 288 71 359 0.003*
 Female 674 101 775
 Total 962 172 1134

Work experience††
 Less than 10 years 264 42 306 0.431*
 10 - 20 years 256 41 297
 21 - 30 years 319 51 370
 More than 30 years 115 27 142
 Total 954 161 1115

Workplace††
 Public 202 34 236 0.945*
 Private 408 72 480
 Both 274 50 324
 Total 884 156 1040

Field ††
 General dentistry 409 52 461 0.067**
 Oral Surgery/Periodontology 109 20 129
 Operative Dentistry/Endodontics 131 27 158
 Paediatric Dentistry/Orthodontics 112 26 138
 Oral Public Health 38 4 42
 Oral Pathology/Oral Radiology 18 6 24
 Total 817 135 952

Use of IPE
 Yes 631 91 722 0.001*
 No 331 81 412
 Total 962 172 1134

Needle stick accidents††
 Yes 829 139 968 0.065*
 No 128 32 160
 Total 957 171 1294

Dental care for hepatitis patients ††
 Yes 264 44 308 0.928*
 No 489 83 572
 Total 753 127 880

Question on patient history of hepatitis ††
 Yes 799 132 931 0.087*
 No 153 36 189
 Total 952 168 1120

Unprotected homo/hetero sex††
 Yes 202 37 239 0.862*
 No 752 133 885
 Total 954 170 1124

Blood transfusion††
 Yes 42 16 58 0.006*
 No 881 147 1028
 Total 923 163 1086

Previous history of hepatitis††
 Yes 100 15 115 0.529*
 No 816 147 963
 Total 916 162 1078

Family history of hepatitis ††
 Yes 227 34 261 0.387*
 No 521 94 615
 Total 748 128 876

Combined question†, ††
 Yes 106 29 135 0.026*
 No 829 137 966
 Total 935 166 1101

* Pearson's chi-square test ** Fisher's exact test

† This question included use of illicit injection drugs, piercings and tattoos, blood transfusion, transplant, history of dialysis, colonoscopy or chemotherapy.

††: For these variables, the sum of the data does not result in 100%, as these questions were not answered by the entire sample.

Table 2.

Adjusted factors associated with self-reporting of hepatitis B vaccination among Brazilian dentists, Belo Horizonte, 2005

Prevalence Ratio
(95%CI)
p-value
Gender
 Female 1.06 (1.02-1.10) 0.006
 Male 1

Use of IPE
 Yes 1.05 (1.01-1.09) 0.021
 No 1

Blood transfusion
 No 1.10 (1.01-1.21) 0.024
 Yes 1

Combined question
 No 1.08 (1.02-1.15) 0.013
 Yes 1

When asked whether they knew their immunization status or had performed a post-vaccination test, 14.8% of the total sample reported having taken the test. Immunization status was associated with work experience (p = 0.003), the use of IPE (p = 0.003), dental care for patients with hepatitis (p = 0.011), the custom of asking patients about hepatitis during dental treatment (p = 0.001) and a family history of hepatitis (p = 0.004) (Table 3). The multivariate analysis revealed that dentists who reporting the use of IPE had a 1.03-fold (95%CI: 1.00-1.07) greater prevalence of vaccination. Dentists who asked patients about hepatitis had a 1.07-fold (95%CI: 1.04-1.11) greater prevalence of immunization. Dentists who reported a family history of hepatitis had a 1.06-fold (95%CI: 1.02-1.12) greater prevalence of immunization. Dentists with less than 10 years of experience had a 1.07-fold (95%CI: 1.02-1.12) greater prevalence of immunization when compared to dentists with more than 30 years of experience. Dentists with 10 to 20 years of experience had a 1.07-fold (95%CI: 1.02-1.13) greater prevalence of immunization when compared to dentists with more than 30 years of experience. There was no difference in the prevalence of immunization between those with 20 to 30 years of experience and those with more than 30 years of experience (Table 4).

Table 3.

Factors associated with self-reporting of hepatitis B post-vaccination test among Brazilian dentists, Belo Horizonte, 2005

Knowledge on immunization status p-value
Yes No Total
Gender
 Male 55 256 311 0.253*
 Female 138 525 663
 Total 193 781 974

Work experience††
 Less than 10 years 65 222 287 0.003*
 10 - 20 years 62 182 244
 21 - 30 years 55 264 319
 More than 30 years 11 99 110
 Total 193 767 960

Workplace††
 Public 45 155 200 0.511*
 Private 76 332 408
 Both 58 221 279
 Total 179 708 887

Field††
 General dentistry 72 328 400 0.085**
 Oral Surgery/Periodontology 35 87 122
 Operative Dentistry/Endodontics 21 104 125
 Paediatric Dentistry/Orthodontics 27 98 125
 Oral Public Health 4 26 30
 Oral Pathology/Oral Radiology 5 11 16
 Total 164 654 818

Use of IPE
 Yes 142 484 626 0.003
 No 51 297 348
 Total 193 781 974

Needle stick accidents††
 Yes 171 663 834 0.227
 No 22 115 137
 Total 193 778 971

Dental care for hepatitis patients ††
 Yes 69 199 268 0.011
 No 89 406 495
 Total 158 605 763

Question on patient history of hepatitis ††
 Yes 176 626 802 0.001
 No 17 144 161
 Total 193 770 962

Unprotected homo/hetero sex††
 Yes 37 157 194 0.790
 No 154 619 773
 Total 191 776 967

Blood transfusion††
 Yes 7 40 47 0.393
 No 179 717 896
 Total 186 757 943

Previous history of hepatitis††
 Yes 23 77 100 0.459
 No 164 662 826
 Total 187 739 926

Family history of hepatitis ††
 Yes 61 164 225 0.004
 No 96 444 540
 Total 157 608 765

Combined question†, ††
 Yes 26 107 188 0.935
 No 162 654 761
 Total 188 816 949

* Pearson's chi-square test ** Fisher's exact test

† This question included use of illicit injection drugs, piercings and tattoos, blood transfusion, transplant, history of dialysis, colonoscopy or chemotherapy.

††: For these variables the sum of the data does not result in 100% as these questions were not answered by the entire sample.

Table 4.

Adjusted factors associated with self-relating of hepatitis B post-vaccination test among Brazilian dentists, Belo Horizonte, 2005

Prevalence Ratio
(95%CI)
p-value
Use of IPE
 Yes 1.03 (1.0-1.07) 0.038
 No 1

Question on patient history of hepatitis
 Yes 1.07 (1.04-1.11) < 0.001
 No 1

Family history of hepatitis
 Yes 1.06 (1.02-1.10) 0.003
 No 1

Work experience
 Less than 10 years 1.07 (1.02-1.12) 0.004
 10 - 20 years 1.07 (1.02-1.13) 0.006
 21 - 30 years 1.02 (0.98-1.17) 0.262
 More than 30 years 1

Discussion

Prevention is ultimately the most efficient and humane means toward improved health [33]. Immunization programs are highly effective, clearly protect populations and individuals at risk and are leading to the elimination of hepatitis B [34]. Viral hepatitis is preventable with effective vaccines, which have been available since 1982 and have proven safe to both adults and children [7,10]. However, despite being safe, efficacious and cost-effective, hepatitis B vaccination remains consistently under-employed [34].

Reports from different countries reveal that some dentists do not engage in safe practices, such as the use of gloves, facemasks or protective eyeglasses. Moreover, hepatitis B virus vaccination coverage is not complete among dentists, as reported for countries such as Nigeria, Jordan, Iran and the United Kingdom [17-23].

The results of the present study reveal that an average of 73.8% of the dentists had taken the three doses of the hepatitis B vaccine. The Brazilian Ministry of Health offers the National Viral Hepatitis Program, which has provided free vaccinations for newborn children, adolescents, those who work in the sex industry and healthcare workers since 1998. Thus, a higher number of vaccinated dentists was expected. However, this is a good coverage compared to countries that do not have government vaccination programs, such as Kenya, where only 12.8% of healthcare workers have been vaccinated for hepatitis B [23]. It is important to point out the differences between the two studies: The present study was carried out in a large city, whereas the Kenyan study was carried out in Thika, which is a typical small Kenyan district [23]. The number of vaccinated dentists in the present study was also higher than that reported for correctional healthcare workers in three American states, in which only 64% of the 411 professionals interviewed reported having received all three doses of the vaccine [35]. On the other hand, vaccination coverage among English dentists is quite higher than that reported in the present study [22].

Female dentists, dentists who use IPE and those who reported the use of illicit drugs had a greater prevalence of vaccination for hepatitis B. A study carried out in the city of Recife (Brazil) found that women adhere to infection control measures more than male dentists [36]. It is troubling that dentists who use illicit drugs and those with a history of blood transfusion have a lower proportion of adherence to the vaccination than those who do not report these factors, considering the increased risk [2]. On the other hand, it appears that the dentists who adhere more to infection control measures, such as the use of EPI, also have a higher prevalence of vaccination. This finding is similar to that reported in a study carried out in Iran [20].

Regarding vaccination status, there were no differences in relation to work experience. This may be explained by the fact that all the three dental schools in the city of Belo Horizonte offer an immunization program for their students before initiating dental practice, which explains why most of the dentists are vaccinated, especially those recently graduated. Those with a longer-standing profession may have been vaccinated during a campaign by the Dental Council of Minas Gerais in 1996, when all dentists in the state were offered free vaccinations. However, vaccination goes beyond taking vaccines; it implies a monitoring process, which is seldom considered including all vaccine series and over the lifetimes of individuals [33].

There was a very low prevalence of hepatitis B immunization. Studies carried out in Iran report that dentists take the test for the evaluation of immunization status with a frequency least 2.5-fold greater than Brazilian dentists [20,21]. This finding underscores the need for collective actions for raising the awareness of Brazilian dentists with regard to the evaluation of immunization status for this disease.

Dentists who adequately employ IPE, those who obtain a patient history regarding hepatitis B, those with a family history of hepatitis B and those more recently graduated had a greater frequency of self-reported immunization for hepatitis B. As mentioned above, dentists with a more favourable behaviour with regard to infection control measures are more apt to adhere to an immunization evaluation. Living with the disease in the family setting may have sensitized these dentists to adhering to every prevention protocol in the professional setting. Likewise, dentist who more recently graduated may have been submitted to a different training/education process in relation to infection control measures. Further education may be appropriate in order to impress upon dental students and dentists alike the importance of knowledge on their own vaccination and immunization status.

The present study has some limitations that must be recognized. Cross-sectional studies are carried out either at a single point in time or over a short period. Thus, associations identified in cross-sectional studies should not be considered a causal relationship. However, there is a lack of studies that concomitantly assess the knowledge of dentists regarding their own hepatitis vaccination and immunization status, as we performed in the present study.

Given the huge burden of hepatitis B infection worldwide and the number of advances made in the past several decades, it is surprising that more progress in limiting the infection has not been made. Hepatitis B continues to spread in endemic areas where universal vaccination has not yet been achieved. The availability of the vaccine and its use in preventing neonatal transmission as well as the increasing use of suppressive therapies should yield greater gains in the eradication of hepatitis B in upcoming generations [3,4]. Moreover, dentists should be better instructed with regard to the importance of compliance to the vaccination and taking the post-vaccination test in order to assist in the elimination of hepatitis B.

Conclusions

The prevalence of hepatitis B vaccination among Brazilian dentists was associated to gender, blood transfusion and risk behaviours. A low percentage of dentists reported having taken the post-vaccination test and few were aware of their immunization status. We strongly recommend that dentists, as a potential risk group, should know their immunization status so that those who require revaccination can obtain it.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

VLSR, MHGA, SMP, RT and IAP conceptualized the rationale and design of the study. VLSR and MHGA performed the statistical analysis and interpretation of the data. VLSR, MHGA, SMP and IAP drafted the manuscript. All authors read and approved the final manuscript.

Contributor Information

Vera Lúcia S Resende, Email: silres@gmail.com.

Mauro Henrique G Abreu, Email: maurohenriqueabreu@ig.com.br.

Saul M Paiva, Email: smpaiva@uol.com.br.

Rosângela Teixeira, Email: teixeira@medicina.ufmg.br.

Isabela A Pordeus, Email: isabelapordeus@ufmg.br.

Acknowledgements

The authors are grateful to the Dental Council of Minas Gerais, the State of Minas Gerais Research Foundation (FAPEMIG) and the National Council for Scientific and Technological Development (CNPq).

References

  1. Ammon A, Reichart PA, Pauli G. Hepatitis B and C among Berlin dental personnel: incidence, risk factors, and effectiveness of barrier prevention measures. Epidemiol Infect. 2000;125:407–413. doi: 10.1017/S0950268899004537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. François G, Hallauer J, Van Damme. Hepatitis B vaccination: how to reach risk groups. Vaccine. 2002;21:1–4. doi: 10.1016/S0264-410X(02)00440-1. [DOI] [PubMed] [Google Scholar]
  3. Ocama P, Opio CK, Lee WM. Hepatitis B virus infection: current status. Am J Med. 2005;118:1413. doi: 10.1016/j.amjmed.2005.06.021. [DOI] [PubMed] [Google Scholar]
  4. Ropero AM, Danovaro-Holliday MC, Andrus JK. Progress in vaccination against hepatitis B in the Americas. J Clin Virol. 2005;34:S14–S19. doi: 10.1016/S1386-6532(05)80029-0. [DOI] [PubMed] [Google Scholar]
  5. Sharma SK, Saini N, Chwla Y. Hepatitis B virus: inactive carriers. Virol J. 2005;28:82. doi: 10.1186/1743-422X-2-82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Odusanya OO, Meurice FP, Hoet B. Nigerian medical students are at risk for hepatitis B infection. Trans R Soc Trop Med Hyg. 2007;101:465–8. doi: 10.1016/j.trstmh.2006.08.001. [DOI] [PubMed] [Google Scholar]
  7. Van Damme P, Van Herck K. A review of the long-term protection after hepatitis A and B vaccination. Travel Med Infect Dis. 2007;5:79–84. doi: 10.1016/j.tmaid.2006.04.004. [DOI] [PubMed] [Google Scholar]
  8. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology. 2003;38:4–13. doi: 10.1053/jhep.2003.50310. [DOI] [PubMed] [Google Scholar]
  9. Xiao-wen H, Shu-han S, Zhen-lin H, Jun L, Lei J, Feng-juan Z, Ya-nan Z, Ying-jun G. Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HbsAG by protein boosting. Vaccine. 2005;23:1649–56. doi: 10.1016/j.vaccine.2004.10.013. [DOI] [PubMed] [Google Scholar]
  10. WHO. World Health Organization Hepatitis C. Fact Sheets. 2000. http://www.who.int/mediacentre/factsheets/en/ Acessed December 18 h, 2009.
  11. Fry DE. Occupational blood-borne diseases in surgery. Am J Surg. 2005;190:249–54. doi: 10.1016/j.amjsurg.2005.05.021. [DOI] [PubMed] [Google Scholar]
  12. Cottone JA, Puttaiah R. Hepatitis B virus infection. Current status in dentistry. Dent Clin North Am. 1996;40:293–307. [PubMed] [Google Scholar]
  13. Deisenhammer S, Radon K, Nowak K, Reichert J. Needlestick injuries during medical training. J Hosp Infect. 2006;63:263–7. doi: 10.1016/j.jhin.2006.01.019. [DOI] [PubMed] [Google Scholar]
  14. Fitzsimons D, François G, Hall A, McMahon B, Meheus A, Zanetti A, Duval B, Jilg W, Böcher WO, Lu SN, Akarca U, Lavanchy D, Goldstein S, Banatvala J, Damme PV. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine. 2005;22:4158–66. doi: 10.1016/j.vaccine.2005.03.017. [DOI] [PubMed] [Google Scholar]
  15. Abe M, Abkar SM, Onji M. Zinc and hepatitis B virus immunization. Hepatol Res. 2006;35:1–2. doi: 10.1016/j.hepres.2006.02.010. [DOI] [PubMed] [Google Scholar]
  16. Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, Kaslow RA. HLA and cytokine gene polymorphisms are independently associate with responses to hepatitis B vaccination. Hepatology. 2004;39:978–88. doi: 10.1002/hep.20142. [DOI] [PubMed] [Google Scholar]
  17. Sofola OO, Ui OG. Hepatitis B virus infection and prevention in the dental clinic: knowledge and factors determining vaccine uptake in a Nigerian dental teaching hospital. Nig Q J Hosp Med. 2008;18:145–8. [PubMed] [Google Scholar]
  18. Uotomi IL. Attitudes of Nigerian dentists towards hepatitis B vaccination and use of barrier techniques. West Afr J Med. 2005;24:223–6. doi: 10.4314/wajm.v24i3.28201. [DOI] [PubMed] [Google Scholar]
  19. Al Negrish A, Al Momani AS, Al Sharafat F. Compliance of Jordanian dentists with infection control strategies. Int Dent J. 2008;58:231–6. doi: 10.1111/j.1875-595x.2008.tb00193.x. [DOI] [PubMed] [Google Scholar]
  20. Alavian SM, Akbari H, Ahmadzad-Asl M, Kazem M, Dvoudi A, Tavangar H. Concerns regarding dentist's compliance in hepatitis B vaccination and infection control. Am J Infect Control. 2005;33:428–9. doi: 10.1016/j.ajic.2005.04.243. [DOI] [PubMed] [Google Scholar]
  21. Alavian SM, Izadi M, Zare AA, Lankarani MM, Assari S, Vardi MM. Survey of the level of anti-HBs antibody titer in vaccinated Iranian general dentists. Spec Care Dentist. 2008;28:265–70. doi: 10.1111/j.1754-4505.2008.00052.x. [DOI] [PubMed] [Google Scholar]
  22. Rhodes A, Aw TC, Allen C, Ridout M. Immunization status of dental practice staff in Kent. Br Dent J. 2008;205:E20. doi: 10.1038/sj.bdj.2008.999. [DOI] [PubMed] [Google Scholar]
  23. Suckling RM, Taegtmeyer M, Nguku PM, Al-Abri SS, Kibaru J, Chakaya JM, Tukei PM, Gilks CF. Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake. J Hosp Infect. 2006;64:271–7. doi: 10.1016/j.jhin.2006.06.024. [DOI] [PubMed] [Google Scholar]
  24. Batista SM, Andreasi MS, Borges AM, Lindberg AS, Silva AL, Fernandes TD, Pereira EF, Basmage EA, Cardoso DD. Soropositivity for hepatitis B vírus vaccination coverage, and vaccine response in dentists from Campo Grande, Mato Grosso do Sul, Brazil. Mem Inst Oswaldo Cruz. 2006;101:263–7. doi: 10.1590/S0074-02762006000300006. [DOI] [PubMed] [Google Scholar]
  25. Dean AG, Dean JA, Coulombier D, Burton AH, Brendei KA, Smith DC. Epi Info™, Version 6.04a, a word processing, database, and statistics program for public health on IBM-compatible microcomputers. Atlanta: Centers for Disease Control and Prevention; 1996. [Google Scholar]
  26. Resende VLS, Abreu MHG, Paiva SM, Teixeira R, Pordeus IA. Factors associated with seroprevalence of hepatitis C among dentists of a large Brazilian city. Virology J. 2009;6:228. doi: 10.1186/1743-422X-6-228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Streiner DL, Norman GL. Health measurements scales: a practical guide to their development and use. 2. Oxford: Oxford University; 2005. [Google Scholar]
  28. Machado-Carvalhais HP, Ramos-Jorge ML, Auad SM, Martins LH, Paiva SM, Pordeus IA. Occupational exposure to potentially infectious biological material in dental teaching environment. J Dent Educ. 2008;72:1201–8. [PubMed] [Google Scholar]
  29. Araujo MW, Andreana S. Risk and prevention of transmission of infectious diseases in dentistry. Quintessence Int. 2002;33:376–82. [PubMed] [Google Scholar]
  30. Porter S, Scully C, Samaranayake L. Viral Hepatitis: Current concepts for dental practice. Oral Surg Oral Med Oral Pathol. 1994;78:682–95. doi: 10.1016/0030-4220(94)90082-5. [DOI] [PubMed] [Google Scholar]
  31. Lodi G, Porter SR, Teo CG, Scully C. Prevalence of HCV infection in healthcare workers of UK dental hospital. Br Dent J. 1997;183:329–32. doi: 10.1038/sj.bdj.4809488. [DOI] [PubMed] [Google Scholar]
  32. Sofola OO, Savage KO. Assessment of the compliance of Nigerian dentists with infection control: a preliminary study. Infec Cont Hosp Epidemiol. 2003;24:737–40. doi: 10.1086/502122. [DOI] [PubMed] [Google Scholar]
  33. Ehreth J. The value of vaccination: a global perspective. Vaccine. 2003;21:4105–17. doi: 10.1016/S0264-410X(03)00377-3. [DOI] [PubMed] [Google Scholar]
  34. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ. Advisory Committee on Immunization Practices (ACIP) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54:1–31. [PubMed] [Google Scholar]
  35. Gershon RR, Mitchell C, Sherman MF, Vlahov D, Lears MK, Felknor S, Lubelczyk RA. Hepatitis B vaccination in correctional health care workers. Am J Infect Control. 2005;33:510–8. doi: 10.1016/j.ajic.2005.04.245. [DOI] [PubMed] [Google Scholar]
  36. Brêda-Albuquerque F, de Farias AB, do Prado MG, Orestes-Cardoso S. Influence of clinicians' socio-demographic, professional and educational variables on their compliance with preventive measures against hepatitis B and C. Oral Health Prev Dent. 2008;6:349–54. [PubMed] [Google Scholar]

Articles from Virology Journal are provided here courtesy of BMC

RESOURCES